Literature DB >> 30542797

Osteoporosis: a clinical and pharmacological update.

Maritza Vidal1, Ross J Thibodaux2, Luis Fernando Vidal Neira3,4,5, Osvaldo Daniel Messina6,7.   

Abstract

Osteoporosis is characterized by the loss of bone mass, deterioration of the bone microarchitecture, and an increased risk of fractures; these later complications are associated with significant morbidity and mortality. The asymptomatic and progressive nature of osteoporosis underscores the importance of identifying this entity in early stages. Despite the various treatments available, the prevention of the disease represents the most important aspect of management. An adequate intake of calcium and vitamin D as well as a healthy lifestyle is the basis for maintaining bone health. When osteoporosis is diagnosed, the choice of medications must be individualized considering characteristics of the patient and the risk of fractures. In this article, we review the main causes of osteoporosis, when and how to start treatment, and appropriate therapy and monitoring.

Entities:  

Keywords:  Bone mineral density; Fractures; Osteoporosis; Osteoporosis treatment

Mesh:

Substances:

Year:  2018        PMID: 30542797     DOI: 10.1007/s10067-018-4370-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  N-acetylcysteine prevents orchiectomy-induced osteoporosis by inhibiting oxidative stress and osteocyte senescence.

Authors:  Lulu Chen; Guantong Wang; Qinjue Wang; Quan Liu; Qiang Sun; Lulu Chen
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 2.  Testosterone supplementation and bone parameters: a systematic review and meta-analysis study.

Authors:  G Corona; W Vena; A Pizzocaro; V A Giagulli; D Francomano; G Rastrelli; G Mazziotti; A Aversa; A M Isidori; R Pivonello; L Vignozzi; E Mannucci; M Maggi; A Ferlin
Journal:  J Endocrinol Invest       Date:  2022-01-18       Impact factor: 4.256

3.  Therapeutic Potential of Tauroursodeoxycholic Acid for the Treatment of Osteoporosis.

Authors:  Tae-Keun Ahn; Kyoung-Tae Kim; Hari Prasad Joshi; Kwang Hwan Park; Jae Won Kyung; Un-Yong Choi; Seil Sohn; Seung-Hun Sheen; Dong-Eun Shin; Soo-Hong Lee; In-Bo Han
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

4.  Bone resorption improvement by conditioned medium of stem cells from human exfoliated deciduous teeth in ovariectomized mice.

Authors:  Ayako Maeda; Takashi Kikuiri; Yoshitaka Yoshimura; Yasutaka Yawaka; Tetsuo Shirakawa
Journal:  Exp Ther Med       Date:  2022-02-21       Impact factor: 2.447

5.  Knowledge and Preventive Practices About Osteoporosis Among Elementary School Teachers of Bandar-Abbas in 2020.

Authors:  Ali Nikoobar; Ali-Asghar Kolahi
Journal:  Front Nutr       Date:  2022-04-04

6.  Untargeted metabolomics using liquid chromatography coupled with mass spectrometry for rapid discovery of metabolite biomarkers to reveal therapeutic effects of Psoralea corylifolia seeds against osteoporosis.

Authors:  Fu-Jiang Zhao; Zhao-Bo Zhang; Ning Ma; Xiao Teng; Zhen-Cheng Cai; Ming-Xi Liu
Journal:  RSC Adv       Date:  2019-11-01       Impact factor: 4.036

7.  Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years.

Authors:  Selveta S van Santen; Daniel S Olsson; Marry M van den Heuvel-Eibrink; Mark Wijnen; Casper Hammarstrand; Joseph A M J L Janssen; Gudmundur Johansson; Aart J van der Lely; Sebastian J C M M Neggers
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

8.  Osteoporosis Remission and New Bone Formation with Mesoporous Silica Nanoparticles.

Authors:  Patricia Mora-Raimundo; Daniel Lozano; Manuel Benito; Francisca Mulero; Miguel Manzano; María Vallet-Regí
Journal:  Adv Sci (Weinh)       Date:  2021-06-06       Impact factor: 16.806

Review 9.  Association between Metabolic Syndrome and Osteoporosis: A Systematic Review and Meta-Analysis.

Authors:  Weida Liu; Chuangshi Wang; Jun Hao; Lu Yin; Yang Wang; Wei Li
Journal:  Int J Endocrinol       Date:  2021-07-16       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.